CD274 and neoplasm: In view of the tumor immune microenvironment, the association and feasibility of radiomics-based biomarkers to tumor-infiltrating immune cell (33–36), the response of immunotherapy (37–41), and PD-L1/PD-L2 expression level (42–44) have also been investigated.